SQUAMOUS CELL CARCINOMA OF SKIN
Clinical trials for SQUAMOUS CELL CARCINOMA OF SKIN explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF SKIN trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New enzyme shot takes aim at Hard-to-Treat tumors
Disease control Recruiting nowThis trial tests a new drug called N17350, a modified enzyme injected directly into tumors, in adults with advanced solid tumors that have not responded to standard treatments. The study aims to find the safest and most effective dose, and to see if the drug can shrink or stop tu…
Matched conditions: SQUAMOUS CELL CARCINOMA OF SKIN
Phase: PHASE1, PHASE2 • Sponsor: Onchilles Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New immune drug AZD6750 targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug, AZD6750, that helps the immune system fight cancer. It is for adults with advanced solid tumors like melanoma, lung, or breast cancer that have not responded to other treatments. The goal is to find the safest dose and see if it shrinks tumors when us…
Matched conditions: SQUAMOUS CELL CARCINOMA OF SKIN
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Blood test may spot head and neck Cancer's return
Knowledge-focused Recruiting nowThis study looks at whether a blood test that finds tumor DNA can predict if head and neck cancer comes back after treatment. About 250 adults who have finished curative treatment will give blood samples over time. The goal is to see if a positive test result matches cancer relap…
Matched conditions: SQUAMOUS CELL CARCINOMA OF SKIN
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC